Zeniquin 50 mg Film-Coated Tablets

زينيكوين 50 مجم أقراص مغلفة للكلاب والقطط

Compare
Pharmaceutical

Zeniquin (marbofloxacin) 50 mg is a synthetic, broad-spectrum fluoroquinolone antibacterial film-coated tablet for dogs and cats. Indicated for the treatment of infectious diseases associated with bacteria susceptible to marbofloxacin, particularly skin, soft tissue, and urinary tract infections.

Dosage Form

N/A

Product Type

Pharmaceutical

Manufacturer

Zoetis

Package

Bottles of 100 or 250 scored film-coated tablets

Dosages

Species Dosage Route Duration
Dog 2.75 to 5.5 mg/kg (1.25 to 2.5 mg/lb) body weight orally once daily (one 50 mg tablet per 9 to 18 kg) Oral tablet Continue treatment for 2 to 3 days beyond cessation of clinical signs, up to 30 days
Cat 2.75 to 5.5 mg/kg (1.25 to 2.5 mg/lb) body weight orally once daily Oral tablet Continue treatment for 2 to 3 days after resolution, maximum 30 days

Withdrawal Periods

No withdrawal information available.

Indications

  • Treatment of skin and soft tissue infections (wounds, abscesses, cellulitis, superficial and deep pyoderma) caused by susceptible strains of Staphylococcus pseudintermedius, E. coli, Proteus mirabilis.

  • Treatment of urinary tract infections (cystitis) in dogs and cats caused by susceptible strains of E. coli and Proteus mirabilis.

Contraindications

  • Do not use in immature, growing dogs: small/medium breeds under 8 months; large breeds under 12 months; giant breeds under 18 months, due to potential cartilage erosion.

  • Do not use in animals with known hypersensitivity to fluoroquinolones.

Precautions

  • Quinolones may cause CNS stimulation; use with caution in animals with diagnosed or suspected seizure disorders.

Side Effects

  • Mild and transient inappetence, vomiting, lethargy, or loose stools.

Images

Documents

  • Zeniquin 50 mg Film-Coated Tablets Prescribing Information

    Leaflet
    Download

Active Ingredients

Diseases

No diseases linked.

Related Products

No data available

Information has not been added yet.

Companies

Alternatives

No alternatives available.

This website uses cookies to ensure you get the best experience.